Prognostic significance of early changes in serum biomarker levels in patients with newly diagnosed metastatic prostate cancer

We evaluated the impact of early changes in serum biomarker levels on the survival of patients with metastatic hormone-sensitive prostate cancer (mHSPC) who were initially treated with androgen deprivation therapy (ADT). We retrospectively investigated 330 patients with mHSPC whose serum maker level...

Descripción completa

Detalles Bibliográficos
Autores principales: Narita, Shintaro, Nomura, Kyoko, Hatakeyama, Shingo, Takahashi, Masahiro, Sakurai, Toshihiko, Kawamura, Sadafumi, Hoshi, Senji, Ishida, Masanori, Kawaguchi, Toshiaki, Ishidoya, Shigeto, Shimoda, Jiro, Sato, Hiromi, Mitsuzuka, Koji, Tochigi, Tatsuo, Tsuchiya, Norihiko, Ohyama, Chikara, Arai, Yoichi, Nagashima, Kengo, Habuchi, Tomonori
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6700107/
https://www.ncbi.nlm.nih.gov/pubmed/31427687
http://dx.doi.org/10.1038/s41598-019-48600-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6700107/
https://www.ncbi.nlm.nih.gov/pubmed/31427687
http://dx.doi.org/10.1038/s41598-019-48600-8

Ejemplares similares